# The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia

> **NCT06717945** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 320 (estimated)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** remimazolam besylate
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT06717945
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2025-05
- **Final completion:** 2025-06
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06717945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06717945, "The Efficacy and Safety of Remimazolam Besylate for Cardiac Anesthesia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06717945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*